CCT196969

CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, LCK, and the p38 MAPKs.

Price Not Available 5 mg CCT196969 Supplier Page
Catalog Number T4133
Research Area Angiogenesis|||MAPK|||Tyrosine Kinase/Adaptors
Molecular Formula C27H24FN7O3
CAS# 1163719-56-9
Purity 99.65%
SMILES CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)cc2F)n(n1)-c1ccccc1
Size 5 mg
Supplier Page https://www.targetmol.com/compound/CCT196969
Additional Information https://www.targetmol.com/datasheet/T4133